Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-022176
Filing Date
2011-03-04
Accepted
2011-03-04 16:05:58
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c13382e10vk.htm 10-K 1235364
2 EXHIBIT 23.1 c13382exv23w1.htm EX-23.1 1389
3 EXHIBIT 31.1 c13382exv31w1.htm EX-31.1 9210
4 EXHIBIT 31.2 c13382exv31w2.htm EX-31.2 9225
5 EXHIBIT 32.1 c13382exv32w1.htm EX-32.1 4045
6 EXHIBIT 32.2 c13382exv32w2.htm EX-32.2 3778
7 GRAPHIC c13382c1338201.gif GRAPHIC 21387
  Complete submission text file 0000950123-11-022176.txt   1293668
Mailing Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130
Business Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 11664708
SIC: 2834 Pharmaceutical Preparations